NOTICE OF ALLOWANCE - ISSUED
issued
on 20 Aug 2024
Last Applicant/ Owned by
19 Point West Drive
Winnipeg, MB
CA
R3T5J4
Serial Number
98166206 filed on 06th Sep 2023
Registration Number
N/A
Correspondent Address
Adriano Pacifici
Adriano Pacifici INTELLECTUAL PROPERTY CONSULTING, LLC
SUITE 1400
NEW ORLEANS, LA 70130
United States
Filing Basis
1. intent to use
2. intent to use current
Disclaimer
NO DATA
UTRAP
Lipid nanoparticles for use in the manufacture of pharmaceuticals, namely, for use in the manufacture of pharmaceutical preparations containing surface chemistry for attachment of any protein, peptide and molecule to bind proteins of interest for preventing and treating viruses, respiratory disorders, rare diseases, cancers, neurological disorders, cardiovascular disorders, inflammatory disorders, Read More
Classification Information
Class [005]
Pharmaceutical Products
Pharmaceutical products, namely, lipid nanoparticles, for treating respiratory diseases; Pharmaceutical preparations for treating respiratory diseases, namely, a lipid-enabled drug for binding to agents of interest in particular viruses, bacteria, free-circulating proteins in the body; Pharmaceutical agents for treating respiratory diseases in the nature of biological blocking agents in the form of lipid nanoparticles that facilitate the binding of viruses, bacteria, protein of interest in biological fluids; Pharmaceutical preparations for the treatment of diseases and disorders, namely, allergies, autoimmune diseases, cancer, cardiovascular diseases, genetic diseases, hematological diseases, infectious diseases, inflammatory diseases, metabolic diseases, neurological diseases, ocular diseases and respiratory diseases
First Use Date in General
N/A
First Use Date in Commerce
N/A
Class [001]
Chemical Products
Lipid nanoparticles for use in the manufacture of pharmaceuticals, namely, for use in the manufacture of pharmaceutical preparations containing surface chemistry for attachment of any protein, peptide and molecule to bind proteins of interest for preventing and treating viruses, respiratory disorders, rare diseases, cancers, neurological disorders, cardiovascular disorders, inflammatory disorders, immunoregulatory disorders, and metabolic disorders; Biochemical preparations for scientific medical research for use in the manufacture of pharmaceuticals for preventing and treating viruses, respiratory disorders, rare diseases, cancers, neurological disorders, cardiovascular disorders, inflammatory disorders, immunoregulatory disorders, metabolic disorders; Reagents for scientific research and medical research use; Chemical reagents for non-medical purposes; Diagnostic reagents for clinical or medical laboratory use; chemistry reagents for scientific research and medical research use; Reagents comprised of nanoparticles for scientific research and medical research use; Reagents comprised of capsids for scientific research and medical research use; Reagents, namely, lipid nanoparticles, for scientific research and medical research use
First Use Date in General
N/A
First Use Date in Commerce
N/A
Mark Details
Serial Number
No 98166206
Mark Type
No Service/Collective Mark
Attorney Docket Number
No 02455
44D Filed
No
44D Current
No
44E filed
No
44E Current
No
66A Filed
No
66A Current
No
Current Basis
No
No Basis
No
Legal History
| Status Date | Action Taken |
|---|---|
| 20th Aug 2024 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| 25th Jun 2024 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| 25th Jun 2024 | PUBLISHED FOR OPPOSITION |
| 05th Jun 2024 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| 16th May 2024 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| 13th May 2024 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| 13th May 2024 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| 13th May 2024 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| 03rd May 2024 | NON-FINAL ACTION WRITTEN |
| 03rd May 2024 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |